Cytokine Profile in Human Peripheral Blood Mononuclear Leukocytes Exposed to Immunoadjuvant and Adjuvant-Free Vaccines Against Influenza
- PMID: 32695114
- PMCID: PMC7339108
- DOI: 10.3389/fimmu.2020.01351
Cytokine Profile in Human Peripheral Blood Mononuclear Leukocytes Exposed to Immunoadjuvant and Adjuvant-Free Vaccines Against Influenza
Abstract
Background: In the last decade, adjuvant-containing vaccines, exerting different effects on the immune system, including the production of cytokines, which are one of the most important regulatory systems of the body, are introduced into practice. Objectives: An effect of the immunoadjuvant polymer-subunit and adjuvant-free vaccines against influenza on the cytokine profile of mononuclear leukocytes in 27 healthy women was studied. Methods: The study of cytokine profile in human peripheral blood mononuclear leukocytes exposed to vaccines against influenza virus was determined by flow cytometry method (Cytomix FC-500, Beckman Coulter, USA) using the Multiplex-13 test system (Bender MedSystems, Austria). Results: It was established that all the studied vaccines leaded to somewhat increased levels of Th1/Th2/Th17/Th9/Th22 cytokines in the culture fluid of peripheral blood mononuclear leukocytes (PBML), which indicates the activation of both humoral and cellular immunity. An immunoadjuvant vaccine has been shown to be superior in activating the synthesis of Th1 (IL-12, INF-g, IL-2, IL-6, IL-1β, TNF-α) cytokines, IL-9 and IL-22, while the subunit vaccine was superior in activating the synthesis of IL-4, and split vaccine-of IL-5. Conclusions: Immunoadjuvant vaccine is superior in terms of inducing cellular immune effectors to a greater extent compared to subunit and split vaccines.
Keywords: cytokine response; split vaccine; subunit immunoadjuvant vaccine; subunit vaccine; vaccines against influenza.
Copyright © 2020 Kostinov, Akhmatova, Khromova and Kostinova.
Figures



Similar articles
-
Assessing human B cell responses to influenza virus vaccines and adjuvants in a PBMC-derived in vitro culture system.Vaccine. 2025 Jan 12;44:126563. doi: 10.1016/j.vaccine.2024.126563. Epub 2024 Dec 2. Vaccine. 2025. PMID: 39616951
-
A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses.Influenza Other Respir Viruses. 2008 Nov;2(6):251-60. doi: 10.1111/j.1750-2659.2008.00054.x. Influenza Other Respir Viruses. 2008. PMID: 19453402 Free PMC article. Review.
-
Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.Vaccine. 2014 Sep 29;32(43):5730-9. doi: 10.1016/j.vaccine.2014.08.029. Epub 2014 Aug 27. Vaccine. 2014. PMID: 25173481
-
Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model.Hum Vaccin. 2010 Jul;6(7):585-94. doi: 10.4161/hv.6.7.11818. Hum Vaccin. 2010. PMID: 20421727
-
Advances in protein subunit vaccines against H1N1/09 influenza.Front Immunol. 2024 Nov 22;15:1499754. doi: 10.3389/fimmu.2024.1499754. eCollection 2024. Front Immunol. 2024. PMID: 39650643 Free PMC article. Review.
Cited by
-
Comb-structured mRNA vaccine tethered with short double-stranded RNA adjuvants maximizes cellular immunity for cancer treatment.Proc Natl Acad Sci U S A. 2023 Jul 18;120(29):e2214320120. doi: 10.1073/pnas.2214320120. Epub 2023 Jul 10. Proc Natl Acad Sci U S A. 2023. PMID: 37428918 Free PMC article.
-
Clinical status and cytokine profiles in patients with asthma or chronic obstructive pulmonary disease vaccinated against influenza.PLoS One. 2025 Feb 12;20(2):e0313539. doi: 10.1371/journal.pone.0313539. eCollection 2025. PLoS One. 2025. PMID: 39937802 Free PMC article.
-
PA-X protein of H1N1 subtype influenza virus disables the nasal mucosal dendritic cells for strengthening virulence.Virulence. 2022 Dec;13(1):1928-1942. doi: 10.1080/21505594.2022.2139474. Virulence. 2022. PMID: 36271710 Free PMC article.
-
The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus.Front Immunol. 2025 May 5;16:1566225. doi: 10.3389/fimmu.2025.1566225. eCollection 2025. Front Immunol. 2025. PMID: 40391210 Free PMC article.
-
Assessment of In Vitro Models of the Human Buccal Mucosa for Vaccine and Adjuvant Development.Mol Pharm. 2025 Jun 2;22(6):2868-2880. doi: 10.1021/acs.molpharmaceut.4c01186. Epub 2025 Mar 26. Mol Pharm. 2025. PMID: 40139941
References
-
- Thomas M, Pierson M, Uprety T, Zhu L, Ran Z, Sreenivasan CC, et al. . Comparison of porcine airway and intestinal epithelial cell lines for the susceptibility and expression of pattern recognition receptors upon influenza virus infection. Viruses. (2018) 10:E312. 10.3390/v10060312 - DOI - PMC - PubMed
-
- Tarbayeva DA, Kostinov MP, Zagorodnyaya ED, Iozefson SA, Cherdantsev AP. The obstetric and perinatal outcomes of acute respiratory infection-complicated pregnancy in the second trimester of pregnancy. Obstet Gynecol. (2012) 2:67–71.
-
- Tarbayeva DA, Kostinov MP, Iozefson SA, Zagorodnyaya ED. Clinical course and outcomes of influenza A (H1N1) 2009 in pregnant women. J Microbiol Epidemiol Immunobiol. (2011). 4:71–6. - PubMed
-
- Kostinov MP, Cherdantsev AP, Semenova SS, Tarbaeva D, Savisko AA, Serova OF, et al. Obstetric and perinatal outcomes among pregnant women after influenza vaccination and after transferred respiratory infection. Gynecol. (2015) 4:43–6.
-
- Kostinov MP, Cherdantsev AP, Savis'ko AA, Tarbaeva D, Solov'yova IL. True and false reactions in pregnant women to introduction of influenza vaccine. Questions Gynaecol Obstetrics Perinatol. (2011) 10:44–8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical